Specifically, we show that Tau leads to widespread epigenetic alterations, including a progressive Tau-dependent loss of heterochromatin markers, both in a neuroblastoma SH-SY5Y cell line model and in human AD brain tissues. Here, MAPT is linked to Alzheimer disease.